Haemodynamic Monitoring improves patient safety
Deltex Medical’s proven Oesophageal Doppler Monitoring (ODM) system is a vital tool for making clinical decisions. Clinicians use it to keep patients in their haemodynamic “sweet spot”. As a result they can avoid complications known to be associated with surgery or critical care. An unrivalled body of Randomised Controlled Trials (RCTs) support ODM. A recent 420 patient study concludes that ODM guided management reduces post-operative complications. This translates into reduced length of stay, even in patients considered to be at only moderate risk.
By helping clinicians to “avoid the avoidable”, ODM is a key component in delivering better outcomes. This means benefits for patients, reduced costs of care and more efficient use of precious resources.
Accurate, real-time measurement of vital parameters is what underpins ODM. As a result it’s famously the world’s first fluid management and cardiac output monitoring system for flow and pressure measured directly from the aorta. Healthcare providers use it in adults and paediatrics.
One system now delivers optimum haemodynamic monitoring…
Deltex Medical calls its newest software platform TrueVue™. We’ve brought together “best-in-class” alternative monitoring modes in one system. Most noteworthy is ODM, together with Pulse Pressure Waveform Analysis (PPWA) and High Definition Impedance Cardiography (HD-ICG). As a result the clinician has the best possible view of the patient’s haemodynamic state.
…whatever the clinical setting
In featuring different modes, clinicians can use TrueVue on asleep or awake patients. For this reason we’ve provided a product selector to establish which TrueVue technology is suitable for the different patient applications. TrueVue is one system, with class-leading ODM at its heart and other monitoring modes available. It’s the only system to deliver the optimum mode, whatever the clinical setting.